The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a ...

All treatment-related adverse events were mild in severity and did not result in discontinuations ... allergic asthma, ...

SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, as of January 10, 2024 First wet AMD registrational trial ...

Caption: A hospitalized 13-year-old B.C. girl believed to be the first person to acquire H5N1 avian flu in Canada is now out of intensive care and breathing on her own. The source of her infection ...

“I called my colleague at the B.C. Centre for Disease Control and arranged for urgent testing for the H5N1 test, which is for ...

Azithromycin is a versatile antibiotic used to treat a wide variety of bacterial infections, including those affecting the ...

Ocular's pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA®, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic ...